Prev Arrow Stocks

Avantor, Inc. ($AVTR) Stock Forecast: Down 17.0% Today

Morpher AI identified a bearish signal. The stock price may continue to fall based on the momentum of the negative news.

What is Avantor, Inc.?

Avantor, Inc. (NYSE: AVTR) is a global supplier of ultra-high-purity materials for the life sciences and advanced technology industries. Market: The overall market for Avantor today was bearish.

Why is Avantor, Inc. going down?

AVTR stock is down 17.0% on Aug 1, 2025 19:07

  • Avantor's Q2 earnings report fell short of expectations, with adjusted EPS missing estimates and revenue remaining nearly flat organically.
  • The adjusted EBITDA margin decline to 16.6% and the decrease in net income from the previous year contributed to the bearish movement.
  • Investor sentiment may have been negatively impacted by the company's bioprocessing shortfalls, customer headwinds, and continued margin pressure, leading to the stock's decline.
  • The disappointing earnings results and lack of clarity on future performance may have prompted investors to sell off their positions, causing the bearish market movement for Avantor today.

AVTR Price Chart

AVTR Technical Analysis

AVTR News

Avantor Q2 Feels The Impact From Bioprocessing Shortfalls, Customer Headwinds, Continued Margin Pressure - Avantor ( NYSE:AVTR )

Q2 adjusted EPS was 24 cents, which missed the 25 cent estimate; revenue was $1.68 billion, which was nearly flat organically. Adjusted EBITDA margin fell to 16.6%; net income dropped to $64.7 million from $92.9 million YoY. Get special access to three exclusive "Top 10 Stocks" power lists ...

https://www.benzinga.com/markets/earnings/25/08/46806516/avantor-q2-feels-the-impact-from-bioprocessing-shortfalls-customer-headwinds-continued-margin-pr

0 Missing News Article Image Avantor Q2 Feels The Impact From Bioprocessing Shortfalls, Customer Headwinds, Continued Margin Pressure - Avantor  ( NYSE:AVTR )

Avantor, Inc. ( AVTR ) Q2 Earnings Lag Estimates

Avantor (AVTR) delivered earnings and revenue surprises of -4.00% and +0.38%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2648313/avantor-inc-avtr-q2-earnings-lag-estimates

1 Missing News Article Image Avantor, Inc.  ( AVTR )  Q2 Earnings Lag Estimates

Avantor, Inc. Price History

25.03.2025 - AVTR Stock was down 16.0%

  • AVTR's Q1 earnings meeting estimates may have been perceived as lackluster by investors, leading to a bearish movement in the stock.
  • The slight revenue surprise of 1.72% might not have been enough to offset any concerns about the company's future growth prospects.
  • Investors may be looking for stronger signals of growth and performance from AVTR to regain confidence in the stock, contributing to the bearish market movement today.

25.03.2025 - AVTR Stock was down 20.4%

  • Q1 sales for Avantor dropped by 6%, falling $30 million below expectations, which likely influenced the bearish trend.
  • The resignation of CEO Stubblefield, a change in company strategy, and an increased cost savings target of $400 million may have introduced uncertainty and negative sentiment among investors.
  • Despite meeting earnings predictions, a modest revenue surprise of 1.72% may not have been enough to alleviate concerns about the sales decrease and leadership adjustments, contributing to the market's bearish direction.
  • General market volatility likely heightened the stock's decline, in line with observations on unpredictable market fluctuations leading to increased volatility trading.

25.09.2024 - AVTR Stock was down 5.5%

  • The strong bearish movement in AVTR stock could be attributed to profit-taking by investors after the stock beat Q3 earnings estimates. This could indicate that some investors are selling off their positions to lock in profits.
  • The divestiture deal with Audax to sell its clinical services business may have also contributed to the bearish movement, as investors may be uncertain about the impact of this strategic decision on the company's future growth prospects.
  • Despite beating earnings estimates, the slight revenue surprise may have raised concerns among investors about the company's ability to sustain its growth momentum in the coming quarters, leading to a bearish sentiment in the market.
  • Overall, the combination of profit-taking post-earnings beat and uncertainty surrounding the divestiture deal could have driven the bearish movement in AVTR stock today.

15.00.2025 - AVTR Stock was up 1.7%

  • Avantor, Inc. is a leading global provider of products, services, and solutions for professionals in the life sciences and advanced technologies industries. The company aims to enable innovative research and healthcare solutions.
  • CareDx (CDNA) saw a rise in its shares, but recent trends in earnings estimate revisions may not lead to further price increases in the short term. This shift in investor focus could be boosting the stock price of Avantor, Inc.
  • A comparison between Pediatrix Medical Group (MD) and Avantor, Inc. is being made to gauge which stock is more appealing to value investors. This comparison may have underscored the growth potential and value proposition of Avantor, Inc., contributing to its current bullish movement.

28.03.2025 - AVTR Stock was down 5.3%

  • The stock of Avantor witnessed a downward movement during the latest trading session.
  • Analysts revised their projections for Avantor following the first-quarter results, hinting at potential apprehensions about its future performance.
  • Factors such as the company's failure to meet sales expectations, the CEO's resignation, and a strategic shift in direction could have influenced the prevailing negative market sentiment.
  • The overall market outlook for Avantor appears to be influenced by internal organizational changes and external market conditions, leading to a bearish trajectory in the stock's value.

28.03.2025 - AVTR Stock was down 6.0%

  • AVTR stock experienced a bearish movement despite reporting in-line earnings for Q1, with revenues slightly down year-over-year. This could have contributed to the negative market sentiment.
  • Analysts cutting their forecasts after the Q1 results may have added to the bearish pressure on AVTR stock, as it indicates a lack of confidence in the company's future performance.
  • The news of Avantor's CEO stepping down and the company planning a leadership change and strategy shift might have created uncertainty among investors, leading to the bearish market movement.
  • Overall, the combination of missed revenue estimates, analyst downgrades, and leadership changes likely fueled the bearish sentiment surrounding AVTR stock.

06.04.2025 - AVTR Stock was down 5.2%

  • Concerns about margin and growth prompted a downgrade of Avantor by Goldman Sachs, resulting in a substantial decline in the stock price.
  • Avantor's Q1 sales falling below estimates and a decrease in organic sales were contributing factors to the prevalent negative sentiment towards the stock.
  • The downgrade by Goldman Sachs along with the underwhelming sales figures likely added to investor uncertainty, leading to the stock's bearish movement today.

07.07.2024 - AVTR Stock was down 5.0%

  • The bearish movement in AVTR stock today could be attributed to the insider sale of 10,100 shares by EVP, AMEA Christophe Couturier. Insider selling is often perceived negatively by investors as it may indicate a lack of confidence in the company's future prospects.
  • Investors might interpret this insider sale as a signal that someone within the company believes that the stock is overvalued or that there could be challenges ahead.
  • This news could have triggered a sell-off among investors, leading to the bearish movement in AVTR stock as market participants reacted to the insider selling activity.

07.01.2025 - AVTR Stock was down 5.7%

  • Despite surpassing adjusted EPS estimates, Q4 net sales for Avantor declined by 2% YoY, falling short of expectations, potentially contributing to the bearish market response.
  • The forecast of 1%-3% organic revenue growth for 2025 may have underwhelmed investors seeking more robust growth forecasts.
  • The combination of the mixed Q4 earnings report and the absence of a clear beat in earnings expectations likely created investor uncertainty, driving the bearish market trend for Avantor today.

10.05.2025 - AVTR Stock was up 5.2%

  • Avantor's bullish movement today could be attributed to positive market sentiment towards the life sciences and advanced technology sectors.
  • Investors might be optimistic about Avantor's growth potential and strong performance in the industry.
  • The lack of significant negative news or developments related to the company could have also contributed to the bullish movement.

01.07.2025 - AVTR Stock was down 20.5%

  • AVTR's Q2 earnings fell short of estimates, with a -4.00% surprise in earnings and a +0.38% surprise in revenue.
  • The disappointing earnings likely contributed to the bearish movement in AVTR's stock price today.
  • Investors may have reacted negatively to the missed estimates, causing a sell-off in AVTR shares.
  • The market may be cautious about AVTR's future performance based on the clues provided by the Q2 earnings results.

01.07.2025 - AVTR Stock was down 17.0%

  • Avantor's Q2 earnings report fell short of expectations, with adjusted EPS missing estimates and revenue remaining nearly flat organically.
  • The adjusted EBITDA margin decline to 16.6% and the decrease in net income from the previous year contributed to the bearish movement.
  • Investor sentiment may have been negatively impacted by the company's bioprocessing shortfalls, customer headwinds, and continued margin pressure, leading to the stock's decline.
  • The disappointing earnings results and lack of clarity on future performance may have prompted investors to sell off their positions, causing the bearish market movement for Avantor today.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.